Objective To investigate the relationship between anti‐Müllerian hormone (AMH) level and
early pregnancy loss in patients who underwent their first embryo transfer by hormone …

As a novel biomarker, there is inconsistent evidence regarding the association between anti-
Müllerian hormone (AMH) and live birth rate in freezing-all embryo transfer cycles. We aim to …

Objectives To retrospectively analyze the correlation between anti-Müllerian hormone
(AMH) and the number of oocytes obtained by controlled ovarian hyperstimulation (COH) in …

Background: Previous literature suggests high anti-Mullerian hormone (AMH), specifically≥
5 ng/mL, has a negative effect on pregnancy rates following in vitro fertilization transfer (IVF …

STUDY QUESTION Is a low (< 1.0 μg/L) or moderately low (1.0–1.9 μg/L) serum anti-
Müllerian hormone (AMH) level a risk factor for early pregnancy loss in IVF/ICSI with a fresh …

Purpose To explore an interaction effect between serum anti-Müllerian hormone (AMH)
levels and the relative treatment effect of a freeze-all versus a fresh embryo transfer strategy …

Objective The objective of our study was to assess the association between AMH and live
birth among women with elevated AMH undergoing first fresh IVF. Serum antimüllerian …

Abstract Anti-Mullerian Hormone (AMH) is considered to be one of the most relevant
markers of ovarian reserve. However, its association with oocyte quality, pregnancy …

Background Anti-Müllerian hormone (AMH) is used as a biomarker to estimate ovarian
reserve. The relationship between AMH and early miscarriage of in vitro fertilization (IVF) is …

The conflicting results from studies on the predictive capabilities of serum anti-Müllerian
hormone (AMH) for IVF pregnancy outcomes may be attributed to small sample sizes and …